Last reviewed · How we verify
Treatment of central precocious puberty (CPP) (gonadotropin-dependent precocious puberty) in children of both sexes
Approved treatments
- Synarel · Pfizer Inc.
Gonadotropin-releasing hormone agonist medication
Clinical guidelines
- FDA label — 1L
SYNAREL is indicated for treatment of central precocious puberty (CPP) in children of both sexes.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Treatment of central precocious puberty (CPP) (gonadotropin-dependent precocious puberty) in children of both sexes patent landscape — cliff calendar, originator estates, attackable patents
- Treatment of central precocious puberty (CPP) (gonadotropin-dependent precocious puberty) in children of both sexes treatment landscape brief
- Treatment of central precocious puberty (CPP) (gonadotropin-dependent precocious puberty) in children of both sexes treatment updates RSS
Frequently asked questions about Treatment of central precocious puberty (CPP) (gonadotropin-dependent precocious puberty) in children of both sexes
What drugs treat Treatment of central precocious puberty (CPP) (gonadotropin-dependent precocious puberty) in children of both sexes?
Tracked treatments include Synarel.
What is the treatment for Treatment of central precocious puberty (CPP) (gonadotropin-dependent precocious puberty) in children of both sexes?
Standard treatment for Treatment of central precocious puberty (CPP) (gonadotropin-dependent precocious puberty) in children of both sexes includes Synarel. See the treatment landscape page for first-line, second-line and salvage options.
What are the treatment guidelines for Treatment of central precocious puberty (CPP) (gonadotropin-dependent precocious puberty) in children of both sexes?
FDA label publishes guidelines for Treatment of central precocious puberty (CPP) (gonadotropin-dependent precocious puberty) in children of both sexes. 1 guideline references tracked.
Related
- Treatment landscape: Treatment of central precocious puberty (CPP) (gonadotropin-dependent precocious puberty) in children of both sexes patent cliff · Treatment of central precocious puberty (CPP) (gonadotropin-dependent precocious puberty) in children of both sexes CI report
- Treatment: Synarel · Pfizer Inc.
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing